UK farmers are praying for rain as Britain suffers its driest spring in well over a century, which has left the soil parched and crops stunted ...

WHO's annual assembly is expected to adopt a landmark agreement on tackling future pandemics, after a top committee in the UN agency unanimously approved ...

The one-year Loan Prime Rate (LPR), the benchmark for the most advantageous rates lenders can offer to businesses and ...

Shares in Chinese battery giant CATL soared more than 13 percent on its Hong Kong debut Tuesday after raising US$4.6 billion ...

Receiving our second Sao Khue Award is not just an honor – it is a testament to our unwavering commitment to people flow ...

優銳醫藥是一家注重創新的生物製藥公司，擁有研發後期管線和商業化產品組合。優銳醫藥專注於專科護理，在呼吸、疼痛管理、急救護理和缺鐵性貧血等領域建立了差異化的商業化產品和創新產品管線組合。致力於解決亞太地區關鍵的未滿足醫療需求，優銳醫藥憑借「商業+研發」雙輪驅動模式，已成功孵化全球領先的研發後期管線，同時在中國和亞太地區保持自我可持續的商業化運營。更多信息，請訪問 ...

The European Commission on Monday warned that it will monitor Portugal's response to the economic impact of US tariffs ...

東京2025年5月20日 /美通社/ — NIPPON EXPRESS HOLDINGS株式會社欣然宣佈，其通過子公司Nippon Express ( South Asia & Oceania) Pte. Ltd.，已於2025年5月15日完成對孟加拉國境內物流運營商Cold Chain Bangladesh Limited（下稱「CCBL」）20%股權的收購。

The US Supreme Court allowed President Donald Trump's administration to end legal protections that have shielded some 350,000 Venezuelans ...

香港2025年5月20日 /美通社/ — 相達生物科技國際有限公司（下稱「相達生物科技」）今天宣佈成功完成3,400萬美元的A輪融資。相達生物科技是一家創新的生物科技公司，其突破性的尿液基因檢測技術為早期疾病檢測帶來了全新變革。本輪募資為 2019 年以來亞洲診斷技術領域最大規模的 A 輪融資，充分體現投資者對相達生物科技的PHASIFY™ ...

ASUS today announced at Computex 2025 that it is pioneering the next wave of intelligent infrastructure with the launch of ...

Microsoft said its cloud servers will now host Grok from Elon Musk's xAI, days after the chatbot went off the rails with talk of "white genocide" ...